Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Halozyme

Halozyme
1998 FOUNDED
PUBLIC STATUS
201-300 EMPLOYEES
HALO STOCK SYMBOL
$16.51 SHARE PRICE (As of Tuesday Closing)
Description

Halozyme Therapeutics is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Formerly Known As
Global Yacht Services
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Medical Supplies
Stock Exchange
NAS
Primary Office
  • 11388 Sorrento Valley Road
  • San Diego, CA 92121
  • United States

+1 (858) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Halozyme’s full profile, request a free trial.

Halozyme Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$13.24 - $18.76 $2.42B $16.35 -$0.29 846K 146M

Halozyme Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 2,283,685 1,899,175 2,774,621 1,271,685
Revenue 181,885 151,862 316,613 146,691
EBITDA (25,363) (59,364) 85,755 (79,474)
Net Income (42,804) (80,330) 62,971 (103,023)
Total Assets 417,830 440,248 519,945 261,515
Total Debt 91,493 128,498 203,165 216,979
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Halozyme Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Halozyme‘s full profile, request access.

Request full access to PitchBook

Halozyme Executive Team (29)

Name Title Board
Seat
Contact
Info
Helen Torley Chief Executive Officer & Board Member
Laurie Stelzer Chief Financial Officer & Chief Accounting Officer
Kim Life JD Chief Compliance Officer
Michael Paolucci Chief Human Resources Officer & Vice President
Ed Gemo Chief Information Officer & Vice President

8 Former Executives

You’re viewing 5 of 29 executives. Get the full list »

Halozyme Board Members (12)

Name Representing Role Since Contact
Info
000000 000000 Self Chairman & Board Member 000 0000
00000 000000 Halozyme Chief Executive Officer & Board Member 000 0000
00000 0000 Self Board Member 000 0000
0000-000000 0000000 00 Self Board Member 000 0000
0000000 000000000 Self Board Member 000 0000

5 Former Board Members

You’re viewing 5 of 12 board members. Get the full list »